Calcium and Uterine carcinoma in situ - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Calcium?
Calcium has active ingredients of calcium. It is used in osteoporosis. Currently, eHealthMe is studying from 168,872 Calcium users.
What is Uterine Carcinoma In Situ?
Uterine carcinoma in situ (uterine cancer) is found to be associated with 26 drugs and 13 conditions by eHealthMe. Currently, we are studying 24 people who have Uterine carcinoma in situ.
Do you take Calcium and have Uterine carcinoma in situ?
Check whether Uterine carcinoma in situ is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Calcium side effects by duration, gender and age:
- Calcium side effects (168,872 reports)
Uterine carcinoma in situ treatments and more:
- Uterine carcinoma in situ (24 reports)
All the drugs that are associated with Uterine carcinoma in situ:
All the conditions that are associated with Uterine carcinoma in situ:
How the study uses the data?
The study uses data from the FDA. It is based on calcium (the active ingredients of Calcium) and Calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Glutathione and Pain Exacerbated - a second ago
- Glipizide and Thyroid Neoplasm - 11 seconds ago
- Eliquis and Vioxx drug interaction - 14 seconds ago
- Metoclopramide and Pain Exacerbated - 20 seconds ago
- Decadron and Wheezing - 21 seconds ago
- Prednisone and Heart Transplant - 29 seconds ago
- Risperidone and Cathflo Activase drug interaction - 32 seconds ago
- Atorvastatin Calcium and Generalised Erythema - 32 seconds ago
- Combivent Respimat and Atrial Fibrillation Aggravated - 34 seconds ago
- Tacrolimus and Weakness - 36 seconds ago